Corvus Pharmaceuticals, Inc. (CRVS) stock
CRVSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$10.19+0.02 (+0.20%)
Close on Nov 18, 2026Market cap $857.19MP/E –Yield –
Corvus Pharmaceuticals pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Corvus Pharmaceuticals's pe ratio was 30.0× on Jan 31, 2022.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Jan 31, 2022 | 30.0× | −10.2 |
| 2021 | Dec 31, 2021 | 40.2× | – |
See a number that looks wrong?